Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant Paclitaxel and Cisplatin in Head and Neck Cancer
NCT00337532Phase 3Completed
- Sponsor
- Bristol Myers Squibb
- Start
- May 2005
- Primary completion
- Jun 2007
- Modality
- Cytokines & Interferons, Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 3 trial of Paclitaxel Micelles for Injection in head and neck cancer (HNC), sponsored by Bristol Myers Squibb. Started May 2005; status: completed.
02
Drugs
Paclitaxel Micelles for Injection
03
Conditions
head and neck cancer (HNC)
Beyond the preview
Go deeper on NCT00337532.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00337532.